CTLA4 and neoplasm: While both co-stimulatory modulating antibodies depressed the fraction of Tregs in B16 melanoma TIL (Figure 2C), CTLA-4 blockade increased absolute numbers of Tregs in the tumor at day 14, whereas α4-1BB did not (Figure S2C).